BIOM-34. CLINICAL, RADIOGRAPHIC, AND PATHOLOGIC PREDICTORS OF RESPONSE TO ANTI-PD-1 AND ANTI-PD-L1 THERAPY IN IDH-WILDTYPE GLIOBLASTOMA PATIENTS

BACKGROUND: Although monoclonal antibodies targeting PD-1 and its ligand PD-L1 have improved overall survival (OS) for many cancers, recent trials of anti-PD-(L)1 in glioblastoma revealed no OS benefit. However, a small subset of patients appears to benefit, warranting evaluation of predictive marke...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Iorgulescu, Bryan, Lim-Fat, Mary Jane, Qin, Lei, Grant, Gareth, Huang, Raymond, Young, Geoffrey, Reardon, David
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Biomarkers
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650344/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.033
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak